Affiliation:
1. G. N. Gabrichevsky research institute for epidemiology and microbiology, Rospotrebnadzor
2. Diagnostic Clinical Center № 1, Moscow
3. City Clinical Hospital № 67 named after L. A. Vorokhobova
Abstract
Relevance. At the children's oncological hospital guidelines to treat patients with several groups of antibiotics at the same time, which ensures the formation of multi-resistant strains of Clostridium difficile, which have a selective advantage for the Clostridium difficile infection developing, and also cause epidemics and /or in associating with an increase in the severity of Clostridium difficile – infection. Aims. Multidrug resistance Clostridium difficile strains and Clostridium difficile infection rate at pediatric oncological hospital. Results. An investigation of the Clostridium difficile resistance strains carried out among children at the children's oncological hospital. 143 toxigenic strains are resistant to moxifloxacin 72.41%, clindamycin 63.72%, rifampicin 35.54%, tetracycline 26.45%, tigecycline 11.42%, vancomycin 4.4%, metronidazole 3.9%. At the same time, the increase multidrug-resistant strains proportion note at the level of 3–4% per year. However, the rate of Clostridium difficile infection among children at the oncological hospital remained at the level of 0.4% to 3.1% with a downward trend. As a result, statistical calculations showed the absence of correlation between multidrug resistance and morbidity. Conclusions. Detection of multidrug-resistant microorganisms among toxigenic Clostridium difficile strains proves the need for further study of this problem in Russia and the advisability of monitoring Clostridium difficile infection rate and multidrug resistance Clostridium difficile strains at pediatric oncological hospitals.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology
Reference20 articles.
1. Saavedra PHV, Huang L, Ghazavi F, et al. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis. Nature Communications. 2018;9:48–46. doi: 10.1038/s41467-018-07386-5.
2. McFarland L V, Ozen M, Dinleyici EC, et al. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World Journal of Gastroenterology. 2016;22(11):3078–3104. doi: 10.3748/wjg.v22.i11.3078.
3. Vindigni SM, Surawicz CM. C. difficile Infection: Changing Epidemiology and Management Paradigms. Clinical and Translational Gastroenterology. 2015;6(7):e99. doi: 10.1038/ctg.2015.24.
4. Lynch T, Chong P, Zhang J, et al. Characterization of a Stable, Metronidazole-Resistant Clostridium Difficile Clinical Isolate. PLoS One. 2013;8(1):e53757. doi: 10.1371/journal. pone.0053757.
5. Gonchar NV, Lazareva IV, Rychkova SV, et al. Zabolevayemost’ detey sal’monellezom i uroven’ rezistentnosti klinicheskikh shtammov sal’monell k antibakterial’nym preparatam v Sankt-Peterburge. Zhurnal infektologii. 2015;7(1):80–86. (In Russ).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献